These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 5992388

  • 21. [Laparotomy and splenectomy in Hodgkin's disease].
    Nikkanen V, Ojala A, Linna MI.
    Duodecim; 1974; 90(3):178-85. PubMed ID: 4849043
    [No Abstract] [Full Text] [Related]

  • 22. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
    Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS.
    J Clin Oncol; 2003 May 15; 21(10):2026-33. PubMed ID: 12743158
    [Abstract] [Full Text] [Related]

  • 23. [Disease-free survival in children with Hodgkin's disease. Relation to histological findings].
    Aguilar-Martínez MS, González-Chirinos P, Rivera-Márquez HF, Alemán-Velázquez P, Reynoso-García M, Alejo-González F.
    Bol Med Hosp Infant Mex; 1988 Oct 15; 45(10):659-65. PubMed ID: 3196428
    [No Abstract] [Full Text] [Related]

  • 24. Complications of treatment of Hodgkin's disease in children.
    Donaldson SS, Kaplan HS.
    Cancer Treat Rep; 1982 Apr 15; 66(4):977-89. PubMed ID: 7074658
    [Abstract] [Full Text] [Related]

  • 25. [Histological classification of Hodgkin's malignant lymphoma and its importance for prognosis].
    Hamann W, Oehlert W, Musshoff E, Nuss A, Schnellbacher B.
    Dtsch Med Wochenschr; 1970 Jan 16; 95(3):112-6. PubMed ID: 5411221
    [No Abstract] [Full Text] [Related]

  • 26. Hodgkin's disease. A retrospective analysis of 40 primary cases.
    Mill WB, Sala JM, Fogerson VL.
    Mo Med; 1972 Jun 16; 69(6):427-31. PubMed ID: 5028740
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical aspects and prognosis of Hodgkin's disease].
    Gross R, Bredenbröcker H, Schmidt CG, Zach J.
    Internist (Berl); 1981 May 16; 22(5):264-9. PubMed ID: 7019134
    [No Abstract] [Full Text] [Related]

  • 28. Hodgkin's disease: a retrospective analysis of 15 years experience at a large referral centre.
    Chandi L, Kumar L, Kochupillai V, Dawar R, Singh R.
    Natl Med J India; 1998 May 16; 11(5):212-7. PubMed ID: 10997167
    [Abstract] [Full Text] [Related]

  • 29. [Studies on the curability of Hodgkin's disease].
    Glińska H.
    Pol Tyg Lek; 1971 Apr 19; 26(16):591-5. PubMed ID: 5577333
    [No Abstract] [Full Text] [Related]

  • 30. [Hodgkin's disease].
    Hedfors E.
    Lakartidningen; 1975 Oct 08; 72(41):3923-6. PubMed ID: 1177614
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
    Andrieu JM, Asselain B, Bayle C, Teillet F, Clot P, Dana M, Katz M, Brière J, Jacquillat C, Bernard J.
    Bull Cancer; 1981 Oct 08; 68(2):190-9. PubMed ID: 7016225
    [No Abstract] [Full Text] [Related]

  • 34. Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
    Campbell B, Wirth A, Milner A, Di Iulio J, MacManus M, Ryan G.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1538-45. PubMed ID: 16125872
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The prognostic value of staging laparatomy for Hodgkin's disease: experience at the University District Hospital of the University of Puerto Rico.
    Santana JR, Ydrach AA, Marcial VA, Vélez-García E.
    Bol Asoc Med P R; 1983 Jun 01; 75(6):258-62. PubMed ID: 6577871
    [No Abstract] [Full Text] [Related]

  • 37. Staging of Hodgkin's disease. Diagnostic organization.
    Owen DR, Hodgson PE.
    Nebr Med J; 1978 Apr 01; 63(4):111-3. PubMed ID: 643115
    [No Abstract] [Full Text] [Related]

  • 38. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billet AL, Kaste S, Tarbell NJ, Howard S, Friedmann AM, Hurwitz CA, Young JA, Marcus KC, Rai S, Cowan T, Weinstein HJ.
    J Clin Oncol; 2004 Nov 15; 22(22):4541-50. PubMed ID: 15542805
    [Abstract] [Full Text] [Related]

  • 39. [On the radiological therapy of Hodgkin's disease. 2. Therapeutic results after extended-field irradiation (author's transl)].
    Heider KM, Salewski D.
    Radiobiol Radiother (Berl); 1981 Nov 15; 22(6):733-9. PubMed ID: 7335855
    [No Abstract] [Full Text] [Related]

  • 40. Definitive irradiation in the treatment of Hodgkin's disease. Analysis of outcome, prognostic factors, and long-term complications.
    Sears JD, Greven KM, Ferree CR, D'Agostino RB.
    Cancer; 1997 Jan 01; 79(1):145-51. PubMed ID: 8988739
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.